| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition; Other Events
YUTREPIA® (treprostinil) inhalation powder net product sales of $222.7 million in the third quarter of 2026, up 31% from the second quarter of 2026 |
| 10 Nov 2026 | 10-Q |
| 28 Oct 2026 |
Form 4: Boyle Dana, Chief Accounting Officer
Sold 1,581 shares ($68.3K) |
| 28 Oct 2026 |
Form 4: Adair Jason, Chief Business Officer
Sold 688 shares ($29.7K) |
| 14 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
| 13 Oct 2026 |
Form 4: Schundler Russell, General Counsel
Received 10,167 shares by exercise or conversion · Sold 13,692 shares ($390K) |
| 13 Oct 2026 |
Form 4: Saggar Rajeev, Chief Medical Officer
Received 8,016 shares by exercise or conversion · Sold 9,218 shares ($263K) |
| 13 Oct 2026 |
Form 4: Moomaw Scott, Chief Commercial Officer
Received 7,466 shares by exercise or conversion · Sold 8,863 shares ($252K) |
| 13 Oct 2026 |
Form 4: Krepp Sarah, Chief Human Resource Officer
Received 3,178 shares by exercise or conversion · Sold 5,245 shares ($149K) |
| 13 Oct 2026 |
Form 4: Khindri Sanjeev, Chief Development Officer
Sold 1,101 shares ($31.4K) |
| 13 Oct 2026 |
Form 4: Kaseta Michael, CFO and COO
Received 12,877 shares by exercise or conversion · Sold 18,938 shares ($539K) |
| 13 Oct 2026 |
Form 4: Jeffs Roger, Director
Received 28,166 shares by exercise or conversion · Sold 32,744 shares ($933K) |
| 13 Oct 2026 |
Form 4: Boyle Dana, Chief Accounting Officer
Received 3,178 shares by exercise or conversion · Sold 5,892 shares ($168K) |
| 13 Oct 2026 |
Form 4: Adair Jason, Chief Business Officer
Received 10,248 shares by exercise or conversion · Sold 7,301 shares ($208K) |
| 07 Oct 2026 |
Form 4: Bloch Stephen M, Director
Sold 235,477 shares ($6.39M) |
| 30 Sep 2026 |
8-K: Other Events
District Court ruled that two of the six claims asserted against Liquidia are valid and infringed |
| 15 Sep 2026 |
Form 4: Singh Raman, Director
Received 9,024 shares by exercise or conversion ($83.6K) · Sold 9,024 shares ($619K) · Received 8,468 shares by exercise or conversion ($78.8K) · 1 more |
| 14 Sep 2026 | 144 |
| 11 Sep 2026 | 144 |
| 03 Sep 2026 |
Form 4: Krepp Sarah, Chief Human Resource Officer
Sold 274 shares ($18.6K) |
Loading...